Market Overview
The IoMT market encompasses connected medical devices ranging from wearable external sensors and implanted cardiac monitors to stationary hospital equipment such as infusion pumps and imaging systems. In 2025, the market is valued at approximately $284 billion, with projections placing it between $346 billion and $659 billion by 2030 depending on the scope and methodology of analysis. The ecosystem includes hardware devices, software platforms for data aggregation and analytics, and managed services that support deployment and maintenance across clinical and home settings.
- •The market covers three primary product categories: wearable external medical devices, implanted medical devices, and stationary medical devices used in hospitals and clinics.
- •Components are segmented into hardware, software, and services, with applications spanning telemedicine, medication management, patient monitoring, and clinical workflow optimization.
- •Connectivity options include both wired and wireless technologies, with cloud-based and on-premise deployment models serving different institutional needs.
Growth Drivers
An aging global population and the rising prevalence of chronic diseases such as diabetes, cardiovascular conditions, and respiratory disorders are increasing demand for continuous, remote health monitoring solutions. Healthcare systems worldwide are under pressure to reduce costs while improving outcomes, and IoMT technologies enable earlier intervention, fewer hospital readmissions, and more efficient resource allocation. Advances in wireless standards, miniaturized sensors, cloud computing, and artificial intelligence have made connected medical devices more capable, affordable, and interoperable than previous generations.
- •Remote patient monitoring and telehealth adoption accelerated during recent years as providers seek to deliver care outside traditional clinical settings.
- •Government initiatives and regulatory frameworks in North America, Europe, and Asia-Pacific are supporting digital health infrastructure and reimbursement for connected care services.
- •Falling costs of sensors, microprocessors, and wireless modules have lowered barriers to entry for both established medical device manufacturers and new entrants.
Segmentation and Regional Analysis
By product type, wearable external devices including smart watches, continuous glucose monitors, and pulse oximeters represent the largest and fastest-growing segment due to consumer adoption and direct-to-patient sales models. Implanted devices such as pacemakers and neurostimulators constitute a smaller but high-value segment driven by clinical necessity and long replacement cycles. Stationary medical devices used in hospitals, including connected imaging systems and patient beds, remain significant due to institutional procurement budgets and infrastructure upgrade cycles.
- •North America currently leads the global IoMT market, supported by advanced healthcare infrastructure, favorable reimbursement policies, and high adoption of digital health technologies.
- •Asia-Pacific is projected to be the fastest-growing region, fueled by large patient populations, expanding healthcare access, and government investments in smart healthcare initiatives in countries such as China, India, and Japan.
- •Europe maintains a strong position with mature markets in Germany, the United Kingdom, and France, along with robust regulatory frameworks that encourage medical device innovation.
Trends and Outlook
What are the recent trends and outlook?
The convergence of IoMT with artificial intelligence and machine learning is enabling predictive analytics that can identify deteriorating patient conditions before symptoms become critical, shifting care toward proactive intervention models. Interoperability remains a central challenge as the industry works toward seamless data exchange between devices, electronic health records, and health information exchanges under frameworks such as HL7 FHIR. As 5G networks expand globally, they will support higher bandwidth and lower latency for real-time remote monitoring, tele-surgery, and large-scale population health analytics.
- •Cloud-native platforms and edge computing are emerging as preferred architectures for handling the massive data volumes generated by connected medical devices while meeting regulatory requirements for data security and patient privacy.
- •Cybersecurity and data privacy are receiving heightened attention from regulators and healthcare organizations, with standards such as the FDA's pre-market cybersecurity guidance and GDPR shaping product development.
- •Long-term forecasts suggest the market could surpass $1 trillion by the early 2030s as IoMT becomes deeply integrated into value-based care models, personalized medicine, and aging-in-place technologies.
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.